ATE347376T1 - Behandlung von allergien - Google Patents

Behandlung von allergien

Info

Publication number
ATE347376T1
ATE347376T1 AT00128661T AT00128661T ATE347376T1 AT E347376 T1 ATE347376 T1 AT E347376T1 AT 00128661 T AT00128661 T AT 00128661T AT 00128661 T AT00128661 T AT 00128661T AT E347376 T1 ATE347376 T1 AT E347376T1
Authority
AT
Austria
Prior art keywords
medicament
treatment
derivative
allergies
allergenic
Prior art date
Application number
AT00128661T
Other languages
English (en)
Inventor
Vera Dr Mahler
Susanne Dr Vrtala
Roland Dr Suck
Oliver Dr Cromwell
Helmut Dr Fiebig
Dietrich Dr Kraft
Rudolf Dr Valenta
Original Assignee
Biomay Prod & Handel
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Family has litigation
First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=8170855&utm_source=google_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=ATE347376(T1) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.
Application filed by Biomay Prod & Handel filed Critical Biomay Prod & Handel
Application granted granted Critical
Publication of ATE347376T1 publication Critical patent/ATE347376T1/de

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K39/35—Allergens
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K39/35—Allergens
    • A61K39/36—Allergens from pollen
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00—Drugs for immunological or allergic disorders
    • A61P37/08—Antiallergic agents

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Immunology (AREA)
  • Medicinal Chemistry (AREA)
  • Veterinary Medicine (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Public Health (AREA)
  • Animal Behavior & Ethology (AREA)
  • Mycology (AREA)
  • Epidemiology (AREA)
  • Microbiology (AREA)
  • General Chemical & Material Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Pulmonology (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Organic Chemistry (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
  • Peptides Or Proteins (AREA)
  • Medicines Containing Plant Substances (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Lubricants (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
AT00128661T 2000-12-28 2000-12-28 Behandlung von allergien ATE347376T1 (de)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
EP00128661A EP1219300B1 (de) 2000-12-28 2000-12-28 Behandlung von Allergien

Publications (1)

Publication Number Publication Date
ATE347376T1 true ATE347376T1 (de) 2006-12-15

Family

ID=8170855

Family Applications (1)

Application Number Title Priority Date Filing Date
AT00128661T ATE347376T1 (de) 2000-12-28 2000-12-28 Behandlung von allergien

Country Status (6)

Country Link
US (1) US20020187158A1 (de)
EP (1) EP1219300B1 (de)
AT (1) ATE347376T1 (de)
DE (1) DE60032250T2 (de)
DK (1) DK1219300T3 (de)
HK (1) HK1045941B (de)

Families Citing this family (29)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US20030202980A1 (en) * 1995-12-29 2003-10-30 Caplan Michael J. Methods and reagents for decreasing clinical reaction to allergy
US7879977B2 (en) * 1998-01-31 2011-02-01 University Of Arkansas Methods and reagents for decreasing clinical reaction to allergy
CA2319437C (en) * 1998-01-31 2009-06-16 University Of Arkansas Methods and reagents for decreasing allergic reactions
EP1272213B1 (de) 2000-04-06 2006-03-08 SEER Pharmaceuticals, LLC. Microbielles wirkstoffabgabesystem
US8246945B2 (en) * 2000-04-06 2012-08-21 University Of Arkansas Methods and reagents for decreasing clinical reaction to allergy
EP1380290A1 (de) 2002-07-09 2004-01-14 Universitair Medisch Centrum Utrecht Cross-Beta-Strukturweg und seine therapeutische Relevanz
US20080254041A1 (en) * 2003-09-11 2008-10-16 Novozymes A/S Method for Selecting an Immunotherapeutic Preparation
ES2424229T3 (es) 2005-03-18 2013-09-30 Cytos Biotechnology Ag Proteínas de fusión de alérgenos de gato y utilización de las mismas
CA2615078A1 (en) * 2005-07-13 2007-01-18 Crossbeta Biosciences B.V. Methods for determining the effect of a treatment on the cross-.beta. structure content of a protein; selection of treatments and uses thereof
US8114832B2 (en) * 2005-07-13 2012-02-14 Crossbeta Biosciences B.V. Method for detecting and/or removing a protein comprising a cross-beta structure from a pharmaceutical composition
EP2386861A3 (de) 2005-07-13 2012-07-18 Crossbeta Biosciences B.V. Cross-Beta-Struktur-bindende Verbindungen
AT503297B1 (de) * 2006-05-18 2007-09-15 Biomay Ag Allergen-spezifische antikörper
US20080082584A1 (en) * 2006-09-29 2008-04-03 Searete Llc, A Limited Liability Corporation Of The State Of Delaware Computational systems for biomedical data
US20080091730A1 (en) * 2006-09-29 2008-04-17 Searete Llc, A Limited Liability Corporation Of The State Of Delaware Computational systems for biomedical data
US8122073B2 (en) * 2006-09-29 2012-02-21 The Invention Science Fund I Computational systems for biomedical data
US10095836B2 (en) * 2006-09-29 2018-10-09 Gearbox Llc Computational systems for biomedical data
US20080109484A1 (en) * 2006-09-29 2008-05-08 Searete Llc, A Limited Liability Corporation Of The State Of Delaware Computational systems for biomedical data
US10546652B2 (en) * 2006-09-29 2020-01-28 Gearbox Llc Computational systems for biomedical data
US20080082364A1 (en) * 2006-09-29 2008-04-03 Searete Llc, A Limited Liability Corporation Of The State Of Delaware Computational systems for biomedical data
US20080082306A1 (en) * 2006-09-29 2008-04-03 Searete Llc Computational systems for biomedical data
US20080082583A1 (en) * 2006-09-29 2008-04-03 Searete Llc, A Limited Liability Corporation Of The State Of Delaware Computational systems for biomedical data
US10068303B2 (en) * 2006-09-29 2018-09-04 Gearbox Llc Computational systems for biomedical data
US20080082367A1 (en) * 2006-09-29 2008-04-03 Searete Llc, A Limited Liability Corporation Of The State Of Delaware Computational systems for biomedical data
US20080082359A1 (en) * 2006-09-29 2008-04-03 Searete Llc, A Limited Liability Corporation Of State Of Delaware Computational systems for biomedical data
US7853626B2 (en) * 2006-09-29 2010-12-14 The Invention Science Fund I, Llc Computational systems for biomedical data
US10503872B2 (en) * 2006-09-29 2019-12-10 Gearbox Llc Computational systems for biomedical data
US20080082307A1 (en) * 2006-09-29 2008-04-03 Searete Llc Computational systems for biomedical data
US20080082271A1 (en) * 2006-09-29 2008-04-03 Searete Llc Computational systems for biomedical data
EP2058000A1 (de) * 2007-11-08 2009-05-13 Crossbeta Biosciences B.V. Zur Aktivierung von T-Zellen fähige immunogene Zusammensetzung

Family Cites Families (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JP3316535B2 (ja) * 1995-03-28 2002-08-19 アサヒビール株式会社 ダニアレルゲンの改変体およびその製造法
SE9703531D0 (sv) * 1997-09-30 1997-09-30 Rudolf Valenta Non-anaphlactic forms of allergens and their use
AU749749B2 (en) * 1998-03-16 2002-07-04 Alk-Abello A/S Mutant recombinant allergens
US6123456A (en) * 1998-07-01 2000-09-26 General Electric Company Catalytic hydrogenation to remove gas from x-ray tube cooling oil

Also Published As

Publication number Publication date
DK1219300T3 (da) 2007-03-05
US20020187158A1 (en) 2002-12-12
DE60032250T2 (de) 2007-03-15
HK1045941B (en) 2007-06-29
DE60032250D1 (de) 2007-01-18
EP1219300A1 (de) 2002-07-03
HK1045941A1 (en) 2002-12-20
EP1219300B1 (de) 2006-12-06

Similar Documents

Publication Publication Date Title
DE60032250D1 (de) Behandlung von Allergien
DE69400799D1 (de) Verwendung von riluzol zur behandlung von parkinson und den parkinson-syndromen
EA200401473A1 (ru) Предотвращение и лечение амилоидогенного заболевания
CY1110727T1 (el) Παρασκευασματα θετικων κατα gram βακτηριων για τη θεραπεια ασθενειων που περιλαμβανουν μια ανοσολογικη δυσρυθμιση
FI971732A7 (fi) Rokote ja antitoksiini C. difficilen aiheuttaman taudin hoitamiseksi j a estämiseksi
ATE495755T1 (de) Vorbeugung und behandlung von amyloidogenischen krankheiten
ATE510562T1 (de) Anti-ailim antikörper zur behandlung von crohn's
DK1151009T3 (da) Antimikrobielt/endotoksin-neutraliserende polypeptid
DK1079857T3 (da) Meningitidis B/C-kombinationsvacciner
PT1040830E (pt) Medicamento para doencas neurodegenerativas
DE60137337D1 (de) Vorbeugende und therapeutsche monoklonale antikörper gegen vacciniavirusantigene
DK1346041T3 (da) Terapeutiske midler og fremgangsmåder til anvendelse deraf til behandling af en amyloidogen sygdom
DE60231131D1 (de) Vakzine und verwendung davon zur behandlung amyotrophischer lateralsklerose
EP0932613A4 (de) Expressionsblockierung von virulenten faktoren in s. aureus
DE50013843D1 (de) Arzneimittel zur behandlung von darmerkrankungen
DE59605959D1 (de) Verwendung von Immunglobulin-Präparationen zur Herstellung eines Medikaments zur oralen Verabreichung zur Behandlung und Prophylaxe chronischer Schmerzzustände
DE69326627D1 (de) Therapeutisches Mittel gegen drohenden Abortus
DK0588477T3 (da) Medicinsk præparat omfatende TCF-11
DK1492539T3 (da) Statin-terapi til forögelse af kognitiv funktion
BR0311180A (pt) Métodos para o tratamento de doenças e condições respiratórias utilizando um inibidor seletivo da inos
BG101145A (bg) Използване на /s/-аденозил-l-метионин /саме/ i неговите физиологично съвместими соли за лечение нареперфузионно увреждане, причинено от временна фокална исхемиа
DE60234031D1 (de) Mittel zur behandlung allergischer augenerkrankungen
DK0865284T3 (da) Præparater, som indeholder vismut og ét eller flere antimikrobiske midler, til forebyggelse og behandling af gastrointestinale sygdomme
DE69421705D1 (de) Verwendung von Efaroxan und dessen Derivaten zur Herstellung eines Arzneimittels zur Behandlung neurogenerativer Erkrankungen
RU2002130727A (ru) Способ лечения детей и подростков с латентной туберкулезной инфекцией

Legal Events

Date Code Title Description
RER Ceased as to paragraph 5 lit. 3 law introducing patent treaties